Hide metadata

Fibroblast-Mediated Resistance to BRAF Inhibition in Metastatic Melanoma - Effect of drugs targeting PI3K/AKT/mTOR signaling pathway

dc.contributor.authorGawraczynska, Marta
dc.date.accessioned2018-09-07T22:04:35Z
dc.date.available2018-09-07T22:04:35Z
dc.date.issued2018
dc.identifier.citationGawraczynska, Marta. Fibroblast-Mediated Resistance to BRAF Inhibition in Metastatic Melanoma - Effect of drugs targeting PI3K/AKT/mTOR signaling pathway. Master thesis, University of Oslo, 2018
dc.identifier.urihttp://hdl.handle.net/10852/64541
dc.description.abstracteng
dc.language.isoeng
dc.subjectPI3K/AKT/mTOR signaling pathway
dc.subjectFibroblast-Mediated Resistance
dc.subjectMetastatic Melanoma
dc.subjectBRAFi
dc.titleFibroblast-Mediated Resistance to BRAF Inhibition in Metastatic Melanoma - Effect of drugs targeting PI3K/AKT/mTOR signaling pathwayeng
dc.typeMaster thesis
dc.date.updated2018-09-07T22:04:35Z
dc.creator.authorGawraczynska, Marta
dc.identifier.urnURN:NBN:no-66975
dc.type.documentMasteroppgave
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/64541/1/Fibroblast-Mediated-Resistance-to-BRAF-Inhibition-in-Metastatic-Melanoma--Marta-Gawraczynska-.pdf


Files in this item

Name:
Fibroblast-Mediated-Resistance ...
Size:
2.185Mb
Format:
application/
View/Open

Appears in the following Collection

Hide metadata